37:
350:
460:
268:
223:
539:
360:
30:
155:
316:
165:
399:
184:
131:
418:
345:
135:
389:
139:
374:
321:
464:
394:
151:
147:
143:
59:
46:
533:
474:
294:
289:
247:
89:
423:
279:
262:
213:
169:
50:
438:
340:
331:
284:
274:
209:
127:
112:
64:
383:
335:
257:
252:
242:
204:
180:
413:
161:
98:
81:
428:
355:
326:
199:
194:
15:
502:
will show the template collapsed, i.e. hidden apart from its title bar.
467:), it is hidden apart from its title bar; if not, it is fully visible.
407:
459:, meaning that if there is another collapsible item on the page (a
19:
526:
will show the template expanded, i.e. fully visible.
505:
481:
373:
309:
233:
111:
80:
73:
58:
470:To change this template's initial visibility, the
31:
8:
77:
70:
38:
24:
16:
454:initial visibility currently defaults to
351:Tetragalacturonic acid hydroxymethylester
471:
7:
465:table with the collapsible attribute
14:
226:(II, VII, IX, X, protein C and S)
269:thrombopoietin receptor agonist
224:Prothrombin complex concentrate
361:Hemostatic Powder Spray TC-325
1:
556:
156:Valoctocogene roxaparvovec
317:Absorbable gelatin sponge
166:Fidanacogene elaparvovec
400:Aminomethylbenzoic acid
540:Drug templates by ATC
132:Damoctocog alfa pegol
346:Oxidized cellulose
136:Efanesoctocog alfa
449:
448:
419:Alfa1 antitrypsin
390:Aminocaproic acid
375:Antifibrinolytics
369:
368:
305:
304:
140:Efmoroctocog alfa
90:Phytomenadione (K
547:
525:
524:
520:
517:
514:
511:
510:Antihemorrhagics
508:
501:
500:
496:
493:
490:
487:
486:Antihemorrhagics
484:
473:
472:|state=
457:
452:This template's
322:Calcium alginate
78:
71:
60:Antihemorrhagics
47:Antihemorrhagics
40:
33:
26:
17:
555:
554:
550:
549:
548:
546:
545:
544:
530:
529:
522:
518:
515:
512:
509:
506:
498:
494:
491:
488:
485:
482:
461:navbox, sidebar
455:
450:
445:
395:Tranexamic acid
365:
301:
235:
229:
152:Turoctocog alfa
148:Susoctocog alfa
144:Moroctocog alfa
114:
107:
102:
93:
62:
54:
44:
12:
11:
5:
553:
551:
543:
542:
532:
531:
528:
527:
503:
447:
446:
444:
443:
442:
441:
433:
432:
431:
426:
421:
416:
404:
403:
402:
397:
392:
379:
377:
371:
370:
367:
366:
364:
363:
358:
353:
348:
343:
338:
329:
324:
319:
313:
311:
307:
306:
303:
302:
300:
299:
298:
297:
292:
287:
282:
277:
265:
260:
255:
250:
245:
239:
237:
231:
230:
228:
227:
217:
216:
207:
202:
197:
188:
187:
174:
173:
159:
125:
119:
117:
109:
108:
106:
105:
100:
96:
91:
86:
84:
75:
68:
56:
55:
45:
43:
42:
35:
28:
20:
13:
10:
9:
6:
4:
3:
2:
552:
541:
538:
537:
535:
504:
480:
479:
478:
477:may be used:
476:
468:
466:
462:
458:
440:
437:
436:
434:
430:
427:
425:
422:
420:
417:
415:
412:
411:
410:
409:
405:
401:
398:
396:
393:
391:
388:
387:
386:
385:
381:
380:
378:
376:
372:
362:
359:
357:
354:
352:
349:
347:
344:
342:
339:
337:
333:
330:
328:
325:
323:
320:
318:
315:
314:
312:
308:
296:
295:Rafutrombopag
293:
291:
290:Lusutrombopag
288:
286:
283:
281:
278:
276:
273:
272:
271:
270:
266:
264:
261:
259:
256:
254:
251:
249:
248:Carbazochrome
246:
244:
241:
240:
238:
232:
225:
222:
221:combinations:
219:
218:
215:
211:
208:
206:
203:
201:
198:
196:
193:
190:
189:
186:
182:
179:
176:
175:
171:
167:
163:
160:
157:
153:
149:
145:
141:
137:
133:
129:
126:
124:
121:
120:
118:
116:
110:
104:
97:
95:
88:
87:
85:
83:
79:
76:
72:
69:
66:
61:
57:
52:
48:
41:
36:
34:
29:
27:
22:
21:
18:
469:
456:autocollapse
453:
451:
424:C1-inhibitor
406:
382:
280:Avatrombopag
267:
263:Fostamatinib
220:
214:Catridecacog
205:I/Fibrinogen
191:
185:Eptacog alfa
177:
170:Nonacog alfa
122:
99:Menadione (K
23:
439:Ulinastatin
384:amino acids
341:Fibrin glue
332:Epinephrine
285:Eltrombopag
275:Romiplostim
200:II/Thrombin
113:Coagulation
65:coagulation
336:adrenalone
258:Etamsylate
253:Concizumab
243:Batroxobin
178:extrinsic:
123:intrinsic:
497:collapsed
475:parameter
435:unsorted
414:Aprotinin
82:Vitamin K
534:Category
521:expanded
429:Camostat
356:Thrombin
327:Collagen
236:systemic
74:Systemic
408:serpins
192:common:
115:factors
516:state
492:state
463:, or
310:Local
234:Other
210:XIII
128:VIII
181:VII
51:B02
536::
523:}}
507:{{
499:}}
483:{{
168:,
164:/(
162:IX
154:,
150:,
146:,
142:,
138:,
134:,
130:/(
519:=
513:|
495:=
489:|
334:/
212:/
195:X
183:/
172:)
158:)
103:)
101:3
94:)
92:1
67:)
63:(
53:)
49:(
39:e
32:t
25:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.